SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GlaxoSmithkline Consumer Healthcare reply to clarification sought by the exchange

10 Jun 2015 Evaluate

The Exchange had sought clarification from GlaxoSmithkline Consumer Healthcare with respect to news article appearing on Moneycontrol website on June 08, 2015 titled ‘FSSAI orders testing of GSK, ITC fast food brands’. GlaxoSmithkline Consumer Healthcare replied stating that they have not received any communication from FSSAI Authorities regarding our brand Foodles. They will provide all support to the authorities and ensure that we remain in complete compliance with the law. GlaxoSmithKline Consumer Healthcare is a responsible company driven by values and committed to bring the best for our consumers.

The above information is a part of company’s filings submitted to BSE.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Varun Beverages 468.50
Nestle 1279.80
Britannia Inds 5699.45
LT Foods 420.50
Hatsun Agro Product 965.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×